Search

The federal government’s direct equity investments are unprecedented, but there may be more to come. Two sectors are clearly benefiting now, but a handful of others may be next.

There is a potentially nice trading opportunity setting up in cannabis near-term.

When Washington, D.C. lawmakers return from their July 4th break on July 10, they are likely to get down to serious business on the SAFE Banking Act.

This proposed law would boost investor interest in the space because it would allow banks to work with cannabis companies. This would help cannabis companies in several ways.

AmBev, Coca-Cola and PepsiCo were recently recommended in the Dick Davis Dividend Digest.

Manitowoc (MTW) is a construction company that’s benefiting from the rebounding economy.

Canadian stocks are a good way to diversify your portfolio without taking on too much risk. And here’s one Canadian stock that appears quite undervalued.

I’m always noticing trends in the stocks recommended in the Dick Davis Digests. When markets are choppy, advisors recommend a lot of conservative stocks and value stocks that look like good bargains. Sectors like health care and technology and retail have phases as well, driven by news, economic reports and...

A major challenge in 2024 for investors and analysts alike will be separating the artificial intelligence (AI) “pretenders” from the “contenders.” Super Micro Computer (SMCI), a recent Explorer recommendation, was up 23% this week, and Exscientia (EXAI) shares were up 13% yesterday.

In my view, the best strategy for overseas markets is to play the trends with a contrarian value approach. For example, the Hang Seng China Enterprises index, a closely followed gauge of large Chinese listings in Hong Kong, has fallen about 11% so far this month after losing 14% last year. Foreign investors have sold about 90% of the $33 billion worth of Chinese stocks that they had purchased earlier in 2023 and have continued selling this year.

So today, we go against the grain on China.

Foreign automakers, including electric vehicle (EV) makers, are losing market share in China as the country doubles down on the EV supply chain.

China makes almost all of EV electric motors and refines most of the chemicals used for lithium batteries. China even leads in developing what could be the next generation of technology, sodium batteries.

The market has been ripping higher with broader participation from sectors that weren’t doing much a couple months ago. That’s the good news. And it’s showing up in the charts with the Small Cap Index at multi-month highs (but well below all-time highs). IPOs are starting to find their legs too. The not-so-good news is that the market is looking a little stretched, which could mean a pause or pullback is coming sooner rather than later. But, the market has a way of doing the unpredictable and with so many investors thinking it’s time for break we could see just the opposite. This month we try to play both sides of the ball by spreading things around in different sectors and across market caps. There’s some IPOs, some high growth software and MedTech ideas, and another growth + value name. They all have their own qualities and stand out to me for different reasons right now.

The sharp market break of 2008 has made it clear that the bears are in control, which means you should remain in a highly defensive position. But money has to flow somewhere, and it appears that, for the moment, pharmaceutical and metal stocks are in favor. This week’s Top Ten sports three pharmaceutical stocks, two other medical names and two precious metal stocks – and most of them have good-looking chart patterns. Just be aware that even strong stocks can get hit in bearish environments, so your emphasis should be on building your watch list, holding cash, and making just token new buys until the storm passes. Our favorite pick this week is Pharmaceutical Product Development (PPDI), a steady company whose bottom line is set to accelerate this year. The stock just broke free from a long consolidation after a bullish outlook, which should offer support on any retreat.

Stock Name	Price	Buy Range	Loss Limit
AUXL (AUXL)	0.00	28-31	-
BMRN (BMRN)	0.00	34-37	-
CPHD (CPHD)	0.00	26-30	-
DV (DV)	0.00	53-59	-
GOLD (GOLD)	0.00	38-41	-
LKQX (LKQX)	0.00	19-21	-
MATK (MATK)	0.00	29 1/2 - 31	-
MLNM (MLNM)	0.00	15-16	-
PAAS (PAAS)	0.00	33-36	-
PPDI (PPDI)	0.00	39-44	-

Checking your stocks often probably doesn’t do any harm, but stock watching does reveal something about you as an investor.

Donald Trump could have a big influence on emerging market stocks, especially in China and Russia. Here’s what to look for when he takes office.

Donald Trump’s presidency is supposed to be bad for Chinese stocks. But in his first week on the job, he just did them a big favor.

Agricultural stocks and other food-related investments are a way to feed your portfolio in this worldwide climate of rising demand for more and better food.

It’s still a bull market, but our Cabot Tides are close to the fence and the odds are that the recent burst in selling pressures probably won’t go away overnight.

Arcosa (ACA) released an uninspiring report on Wednesday that was particularly ill-timed given yesterday’s market retreat. The company missed across the board. Revenue was up 2.7% to $459 million, missing by $4.7 million while adjusted EPS of $0.33 missed by $0.08. Guidance for 2021 also missed.

It’s been a relatively quiet week in the market, with the major indexes mostly up in the 1% range after this morning’s open, though the action has been news-driven as every economic report and Fed speech is picked over for clues to the path of interest rates.

Perhaps a slogan that best represents American history as well as the American stock market might be - “America Runs on Optimism.”